Microplate Dx

About:

Microplate Dx is a developer of diagnostic technology aimed at significantly reducing fatalities caused by drug-resistant infections.

Website: https://microplatedx.com/

Twitter/X: MicroplateDx

Top Investors: University of Strathclyde, Deepbridge Capital, Scottish Enterprise, SIS Ventures, Thairm Bio

Description:

Microplate Dx is a developer of diagnostic technology aimed at significantly reducing fatalities caused by drug-resistant infections. Microplate Dx, an award-winning spinout company from the University of Strathclyde in Glasgow, focuses on creating innovative diagnostic solutions to combat the significant global health challenge of antimicrobial resistance. Their technology revolves around the ingenious concept of employing highly sensitive biosensor electrodes, enhanced with miniaturized hydrogel deposits containing various antibiotics tailored to the specific infection being detected. The primary mission of Microplate DX is to proactively prevent and manage the proliferation of antimicrobial resistance on a global scale.